Cholangiocarcinoma discoveries and treatment approaches Aug. 28, 2021 Overview Show transcript Overview Cholangiocarcinoma remains a surgical disease, but even with a successful resection the recurrence rate is about 70%. Rory L. Smoot, M.D., surgical oncologist at Mayo Clinic’s campus in Rochester, Minnesota, is an expert on cholangiocarcinoma and other biliary tract cancers. Hear Dr. Smoot discuss the systemic treatments and next-generation sequencing done at Mayo Clinic to extend patients’ lives while even more treatment discoveries are being made. Receive Mayo Clinic news in your inbox. Sign up Related ContentArticlePemigatinib trial seeks to build on targeted advances in cholangiocarcinomaArticleScientific and clinical advances aid in diagnosis, staging and treatment of cholangiocarcinoma VID-20520779 Medical Professionals Cholangiocarcinoma discoveries and treatment approaches